Tofacitinib and Ulcerative keratitis - a phase IV clinical study of FDA data

Summary:

Ulcerative keratitis is reported as a side effect among people who take Tofacitinib (tofacitinib), especially for people who are female, 60+ old, also take Actemra,.

The phase IV clinical study analyzes which people have Ulcerative keratitis when taking Tofacitinib. It is created by eHealthMe based on reports of 5,544 people who have side effects when taking Tofacitinib from the FDA, and is updated regularly.

What is Tofacitinib?

Tofacitinib has active ingredients of tofacitinib. eHealthMe is studying from 5,554 Tofacitinib users. Check the latest studies of Tofacitinib.

What is Ulcerative keratitis?

Ulcerative keratitis (ulcerative inflammation of the cornea) is found to be associated with 295 drugs and 744 conditions by eHealthMe. Check the latest studies of Ulcerative keratitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

5,544 people reported to have side effects when taking Tofacitinib.
Among them, 12 people (0.22%) have Ulcerative keratitis.

Could Tofacitinib cause Ulcerative keratitis?

Among these 12 people:

What is the gender of people who have Ulcerative keratitis when taking Tofacitinib? *

female: 100 %
male: 0.0 %

What is the age of people who have Ulcerative keratitis when taking Tofacitinib? *

What are other drugs people take besides Tofacitinib? *

What are other side effects people have besides Ulcerative keratitis? *

Vision Blurred: 12 people, 100.00%
Joint Pain: 12 people, 100.00%
Facial Pain: 12 people, 100.00%
Eye Swelling: 12 people, 100.00%
Drug Ineffective: 12 people, 100.00%
Discomfort: 12 people, 100.00%
Diarrhea: 12 people, 100.00%
Depression: 12 people, 100.00%
Delirium (wild excitement): 12 people, 100.00%
Cough: 12 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tofacitinib and have Ulcerative keratitis?

- Check whether Ulcerative keratitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tofacitinib:

Tofacitinib (5,554 reports)

Browse all side effects of Tofacitinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ulcerative keratitis:

Ulcerative keratitis (295 drugs)

Browse all the conditions that are associated with Ulcerative keratitis:

Ulcerative keratitis (744 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tofacitinib (the active ingredients of Tofacitinib) and Tofacitinib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.